Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Anthem : Deutsche Bank Adjusts Anthem PT to $460 From $408, Maintains Buy Rating

10/22/2021 | 08:24am EST


© MT Newswires 2021
All news about ANTHEM, INC.
12/02ANTHEM, INC. : Ex-dividend day for
FA
12/01AM Best Affirms Credit Ratings of Anthem, Inc. and Most Subsidiaries; Upgrades Credit R..
BU
11/15MARKETMIND : I fought the Fed and the Fed won
RE
11/10Anthem to Acquire Integra Managed Care for Undisclosed Sum
MT
11/10Anthem, Inc. to acquire Integra Managed Care
BU
11/10Anthem, Inc. entered into an agreement to acquire Integra MLTC, Inc. from Personal-Touc..
CI
11/05Anthem Announces Appearance at Upcoming Conferences
BU
11/04Health insurer Cigna hints at easing COVID-19 pain, backs profit goal
RE
11/03Somatus and Anthem, Inc. Collaborate to Deliver Personalized, Value-Based Kidney Care
BU
11/03Somatus and Anthem, Inc. Collaborate to Deliver Personalized, Value-Based Kidney Care
CI
More news
Analyst Recommendations on ANTHEM, INC.
More recommendations
Financials (USD)
Sales 2021 138 B - -
Net income 2021 6 121 M - -
Net Debt 2021 16 152 M - -
P/E ratio 2021 15,9x
Yield 2021 1,14%
Capitalization 95 872 M 95 872 M -
EV / Sales 2021 0,81x
EV / Sales 2022 0,73x
Nbr of Employees 83 400
Free-Float 99,4%
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | ANTM | US0367521038 | MarketScreener
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 395,00 $
Average target price 465,73 $
Spread / Average Target 17,9%
EPS Revisions
Managers and Directors
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Ramiro G. Peru Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.24.49%95 872
UNITEDHEALTH GROUP28.13%423 193
CIGNA CORPORATION-4.99%66 239
HUMANA INC.2.79%54 203
CENTENE CORPORATION18.36%41 458
MOLINA HEALTHCARE, INC.34.45%16 699